<style face="normal" font="default" size="100%">Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: A randomized phase II study conducted by the hellenic co-operative oncology group</style>

Drupal-Biblio